Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene and cell transfer for specific immunotherapy

M K Brenner1, H E Heslop, C M Rooney

  • 1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas 77030, USA. mkbrenne@msmail.his.tch.tmc.edu

Vox Sanguinis
|August 15, 1998
PubMed
Summary

Cancer immunotherapy is advancing, with gene-modified tumor vaccines and immune cells showing promise. These approaches leverage tumor antigens to stimulate anti-cancer responses, offering clinical benefits and warranting further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

A Practical Guide to 16S rRNA Microbiome Analysis in Musculoskeletal Disorders.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2.

Infection prevention in practice·2021
Same author

Protecting the Microbiota.

The Journal of infectious diseases·2021
Same author

Curative Radiotherapy for Lung Cancer in the UK: International Benchmarking.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon.

The Journal of antimicrobial chemotherapy·2019

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapeutics

Background:

  • Human tumor cells express antigens, sparking interest in immunotherapy.
  • Advances in genetic modification enhance anti-cancer immune responses.

Purpose of the Study:

  • To explore the potential of gene-modified immunotherapies for cancer treatment.
  • To highlight the clinical benefits of current immunomodulatory approaches.

Main Methods:

  • Utilizing gene-modified tumor vaccines.
  • Employing genetically modified cytotoxic T cells.
  • Leveraging modified dendritic cells for immunotherapy.

Main Results:

  • Gene-modified approaches induce immunomodulation.

Related Experiment Videos

  • Clinical benefits are observed in various cancer settings.
  • Demonstrated efficacy of modified tumor vaccines and immune cells.

    • Conclusions:

    • Gene-modified immunotherapies show significant promise in cancer treatment.
    • Further investigation into these approaches is strongly supported.
    • Immunotherapy represents a viable and advancing strategy against cancer.